RIVERHEAD CAPITAL MANAGEMENT LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
RIVERHEAD CAPITAL MANAGEMENT LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$22,000
-24.1%
1560.0%0.00%0.0%
Q2 2019$29,000
+20.8%
156
+3.3%
0.00%0.0%
Q1 2019$24,000
+140.0%
151
+41.1%
0.00%
Q4 2018$10,000
-72.2%
107
-58.4%
0.00%
-100.0%
Q3 2018$36,000
+500.0%
257
+576.3%
0.00%
Q1 2018$6,000380.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders